Morphic Holding

MORF46

$56.990.00%$0.00

MORF46

$56.99

0.00%$0.00

Performance History

Key Stats
Open	$56.99
Prev. Close	$56.98
EPS	-3.83
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	56.99	56.99
52 Week Range	19.34	57.00

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-3.83

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Morphic Holding (MORF)

Morphic Holding Inc (MORF) is a leading biopharmaceutical company that focuses on the discovery and development of oral integrin therapies for the treatment of serious chronic diseases. With a mission to transform the lives of patients, Morphic Holding Inc utilizes its proprietary Morphic Integrin Therapeutics (MInT) technology to design and develop small molecule drugs that target integrins, which are important proteins involved in cellular interactions and signaling. By modulating integrin activity, Morphic Holding Inc aims to address unmet medical needs in various therapeutic areas including autoimmune diseases, fibrosis, and immuno-oncology.

One of the key strengths of Morphic Holding Inc is its extensive expertise in integrin biology and drug discovery. The company has a world-class team of scientists and researchers with deep knowledge in these areas, enabling them to identify and validate novel targets for therapeutic intervention. Morphic Holding Inc's drug discovery platform has also been optimized to efficiently generate lead compounds with improved pharmaceutical properties. This allows the company to rapidly advance its drug candidates through preclinical and clinical development, ultimately bringing innovative therapies to patients in need.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Praveen P. Tipirneni M.D.
Headquarters: Waltham
Employees: 110
Exchange: NASDAQ

Keep an eye on Morphic Holding

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Morphic Holding 's (MORF) price per share?

The current price per share for Morphic Holding (MORF) is $56.99. The stock has seen a price change of $0 recently, indicating a 0.01% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Morphic Holding (MORF)?

For Morphic Holding (MORF), the 52-week high is $57, which is 0.02% from the current price. The 52-week low is $19.34, the current price is 194.6% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Morphic Holding (MORF) a growth stock?

Morphic Holding (MORF) has shown an average price growth of 0.41% over the past three years. It has received a score of 37 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Morphic Holding as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Morphic Holding (MORF) stock price performance year to date (YTD)?

As of the latest data, Morphic Holding (MORF) has a year-to-date price change of 96.99%. Over the last three months, the change has been 117.85%. Over the past six months, the figure is 70.32%. Looking at a longer horizon, the five-year price change stands at 224.18%.

help

Is Morphic Holding (MORF) a profitable company?

Morphic Holding (MORF) has a net income of -$152.1M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$178.69M. Furthermore, the EBITDA is -$211.89M.

help

What is the market capitalization of Morphic Holding (MORF)?

Morphic Holding (MORF) has a market capitalization of $2.86B. The average daily trading volume is 1.11M, indicating the stock's liquidity and investor engagement.